Pyridium
In stock
200mg
from A$59.36
In brief
- In many pharmacies you can buy pyridium without a prescription (OTC in lower strengths); availability varies by country but it is commonly sold over the counter in retail pharmacies and online—higher-strength formulations may require a prescription.
- Pyridium (phenazopyridine) is used for short-term relief of urinary tract pain, burning, urgency and frequency; it works as a topical analgesic on the urinary tract mucosa and has no antibacterial action.
- The usual adult dose is 100–200 mg orally three times daily; do not use for more than 2 days when treating a urinary infection unless advised by a clinician.
- Administration is oral—tablets are the common form (usually 100 mg or 200 mg); capsules and compounded oral suspension are available in some areas.
- Relief often begins within about 30 minutes and may be noticeable within an hour, though onset can vary between individuals.
- Effects typically last around 6–8 hours, which is why it is commonly dosed three times daily.
- Avoid heavy alcohol while taking pyridium; alcohol may worsen dizziness or other side effects and can increase strain on the liver—use caution and discuss with a pharmacist or doctor if concerned.
- The most common side effect is reddish‑orange discoloration of the urine (harmless but may stain clothing); other common effects include headache, dizziness, gastrointestinal upset and skin rash.
- Would you like to try “pyridium” without a prescription?
Basic Pyridium Information
- INN (International Nonproprietary Name): Phenazopyridine.
- Brand Names Available In Australia: Not specified; limited local marketing and not widely sold as an off-the-shelf product in Australia, so check the TGA ARTG and PBS for current authorisations.
- ATC Code: G04BX06.
- Forms & Dosages: Tablets 100 mg and 200 mg, capsules in some countries (~95–99.5 mg), and rare pharmacy-compounded suspension (10 mg/mL).
- Manufacturers In Australia: Not specified; international suppliers include Pfizer and multiple generics in the United States, Terapia S.A. and Zentiva in Eastern Europe, and various manufacturers in Latin America.
- Registration Status In Australia: Not specified; clinicians and pharmacists should verify TGA ARTG registration or authorised import pathways before supply.
- OTC / Rx Classification: Varies internationally — OTC at low strengths in the US and Rx at higher strengths; Australian status is not specified and may require prescription or special supply arrangements.
Critical Warnings & Restrictions
High-Risk Groups (Elderly, Pregnancy, Chronic Illness)
Phenazopyridine can cause dizziness, headache and rare blood disorders such as haemolytic anaemia or methemoglobinaemia.
People with known G6PD deficiency must not take phenazopyridine because of the risk of haemolytic anaemia.
Severe renal insufficiency and anuria are absolute contraindications to use.
Children under 12 years are generally not recommended to take phenazopyridine without specialist advice.
Pregnant and breastfeeding people have insufficient safety data, so use only if a prescriber advises the potential benefit outweighs risk.
Elderly people require renal function monitoring and possible dose reduction when renal impairment is suspected.
Those with liver disease should use phenazopyridine with caution owing to limited data on severe hepatic impairment.
Interaction With Activities (Driving, Workplace Safety Under Australian Law)
Phenazopyridine may cause dizziness or drowsiness in some people.
Do not operate heavy machinery or perform safety-sensitive work if you feel dizzy, drowsy or otherwise impaired after taking a dose.
Employers and safety officers may require medical clearance for people in safety-sensitive roles; follow local workplace policy.
The characteristic urine discolouration (reddish-orange) can be surprising but does not itself impair driving.
Q&A — Can I Drive After Taking It In Australia?
- If you feel unaffected after taking phenazopyridine, driving is usually permissible under Australian road‑safety law.
- If you feel dizzy, drowsy, breathless or otherwise impaired, do not drive and seek medical advice before returning to driving.
- Check workplace policies if you are in a safety-sensitive role; your employer may require assessment or clearance.
- Keep packaging or patient information with you when you present for assessment so clinicians can confirm the drug and dose.
Immediate Safety And Referral Advice For Australian Patients
- Stop the drug and seek urgent care if you notice jaundice, breathlessness, severe fatigue, dark urine or a new widespread rash.
- Bring the medication packaging or a photo of it to the emergency department.
- Seek urgent medical help if you develop signs of methemoglobinaemia such as blue-grey skin, shortness of breath or confusion.
- If you are known to have G6PD deficiency, do not take phenazopyridine and contact your GP immediately if you have taken it by mistake.
Emergency actions checklist: Stop medication, seek urgent medical care, bring packaging, inform staff about G6PD status or renal disease.
Usage Basics
INN, Brand Names Available In Australia
The International Nonproprietary Name (INN) is phenazopyridine.
International brand names include Pyridium® (widely known in the United States) and various generics such as Uropirina in Romania and regional Pyridium/Fenazopiridina products in Latin America.
Phenazopyridine is not widely authorised or marketed across the EU and often requires import or hospital-use arrangements.
In Australia, local brand listings are limited and clinicians should verify TGA ARTG registration or authorised import routes before recommending a specific product.
Legal Classification (TGA-Approved, PBS-Listed)
- ATC Code: G04BX06.
- Classification varies internationally — OTC in low strengths in the US and prescription at 200 mg in many countries.
- In Australia, expect prescription or special supply requirements unless a current TGA ARTG entry indicates otherwise.
- Check the PBS to confirm any subsidy or listing before advising on cost or recommending a product.
| Country/Region | Brand/Notes |
|---|---|
| United States | Pyridium® — Tablets 100 mg, 200 mg; OTC low-strength options in some cases. |
| Romania | Uropirina, Fenazopiridină — Frequently 100 mg tablets; prescription status. |
| Mexico / Brazil | Pyridium, Fenazopiridina — 100 mg and 200 mg tablets; OTC/Rx varies by country. |
| EU / UK | Not widely authorised; often imported and prescription only. |
- INN: Phenazopyridine.
- ATC Code: G04BX06.
- Common Forms: Tablets 100 mg and 200 mg; rare compounded suspension 10 mg/mL.
Dosing Guide
Standard Regimens (PBS Reference Dosing)
- Typical adult dose is 100–200 mg orally three times daily.
- Use is short-term only and should not exceed two days when taken with antibiotics for UTI.
- Phenazopyridine is symptomatic analgesia only and should not replace an antibiotic when one is indicated.
Adjustments For Comorbidities (Renal, Hepatic, Elderly)
Avoid phenazopyridine in severe renal impairment or anuria.
Reduce dose or avoid use in moderate renal impairment and monitor renal function in elderly patients.
Use with caution in hepatic impairment; avoid in severe liver disease due to limited data.
Contraindicated in known G6PD deficiency due to risk of haemolytic anaemia.
Children under 12 years should not take phenazopyridine except on specialist advice.
Q&A — What If I Miss A Dose?
- Take the missed dose as soon as you remember unless the next dose is due soon.
- Do not double the next dose to make up for a missed one.
- If in doubt, continue with the regular schedule and contact your pharmacist or GP for advice.
Adjustment prompts checklist:
- Known G6PD deficiency — do not take; consult prescriber.
- Severe renal impairment — contraindicated; do not take.
- Pregnancy or breastfeeding — discuss with prescriber before use.
- Age under 12 years — specialist dosing only.
Interaction Chart
Food And Drinks (Alcohol, Caffeine, Australian Diet Context)
There are few pharmacokinetic food interactions reported for phenazopyridine.
Avoid alcohol while taking phenazopyridine because it may increase dizziness or drowsiness and can impair performance in shift work or safety-sensitive jobs.
Caffeine has no specific interaction but may mask tiredness while sedating effects occur with other substances.
Common Drug Conflicts
| Interacting Agent | Interaction Type | Clinical Action |
|---|---|---|
| Oxidising Agents (e.g., methylene blue) | Potential increased risk of methemoglobinaemia in susceptible patients | Avoid in G6PD deficiency; consult specialist if concurrent use necessary |
| Drugs Causing Haemolysis | Increased haemolytic risk | Avoid combination in G6PD deficiency; monitor haemoglobin if exposure occurs |
| Other Nephrotoxic Agents | Potential additive renal risk | Monitor renal function; avoid if severe renal impairment |
| Antibiotics | No direct interaction; used together for symptom relief while antibiotics treat infection | Limit phenazopyridine use to 2 days when used with antibiotics |
Urine Test Interference Checklist:
- Inform the laboratory if you are taking phenazopyridine because urine will be reddish-orange and may interfere with dipstick colour-based tests.
- Bring medication packaging or a note to the lab to avoid misinterpretation of urinalysis results.
- Consider delaying non-urgent urine colour–dependent testing until 48–72 hours after stopping the drug if possible.
User Reports & Trends
Patients commonly report rapid relief of burning and urgency within hours of taking phenazopyridine.
Many users are surprised or annoyed by vivid orange/red urine and occasional staining of fabrics.
Some patients express frustration if the product is not stocked locally and ask pharmacists about online or import options.
- Top reported positives: fast symptomatic relief of dysuria.
- Top reported negatives: urine discolouration and nausea or headache in a minority.
- Common concerns: masking a worsening infection if used beyond 48 hours.
- Rare reports: prolonged discolouration and isolated allergic reactions.
- Supply trends: variable online pricing and limited rural availability reported by patients.
Example patient quote (anonymised): “I took pyridium tablets on a Friday night and the burning eased within hours, but I was shocked at how orange my urine was and had to warn my partner.”
[Trend chart placeholder: Reviews By Sentiment — Positive / Neutral / Negative]
Action checklist if systemic signs appear:
- Fever or rigors — see your GP urgently or present to ED.
- Loin or flank pain — suspect complicated UTI; urgent review required.
- Worsening symptoms after 48 hours — see GP for reassessment and possible antibiotics.
Rural patients should check local pharmacy stock or consider telehealth for scripts because supply can be limited outside metropolitan areas.
Access & Purchase Options (Australia)
National Chains (Chemist Warehouse, Priceline, TerryWhite Chemmart)
Check with national chains and independent pharmacies for local stock and brand availability.
If phenazopyridine is not stocked, pharmacists can advise on therapeutic alternatives or authorised import pathways.
Our online pharmacy offers pyridium without a prescription with discreet delivery to Australia in 9-21 days for eligible orders.
Online Pharmacies And Telehealth E-Prescriptions
Use accredited Australian online pharmacies or telehealth services to obtain an electronic prescription if required.
For unregistered local products, pharmacists may suggest importing an authorised brand under appropriate regulatory pathways.
Telehealth can be useful for timely scripts when dysuria requires prompt symptomatic relief while arranging antibiotics.
| Route | Typical Time | Prescription Required | Notes |
|---|---|---|---|
| In-Store Pharmacy | Same day to 2 days | Often | Check stock and brand; pharmacist counselling available |
| Online Australian Pharmacy | 2–14 days | Often | Accredited sites; check postage to rural areas |
| Telehealth E-Prescription | Same day | Yes | Convenient for urgent scripts; follow-up advised |
| Import / Special Access | 9–21 days | Yes | Requires regulatory checks; pharmacist can advise process |
- Check with your local pharmacist for current stock and brand availability.
- If unavailable, ask your GP for an alternative or discuss an import pathway with the pharmacist.
- Use accredited telehealth services for an electronic prescription if you are eligible.
- Plan ahead if you live in a rural area where supply may be limited.
Mechanism & Pharmacology
Simplified Explanation
Phenazopyridine is a urinary tract analgesic that provides topical local relief to the bladder and urethral mucosa.
It reduces symptoms such as burning, urgency and frequency but does not kill bacteria or treat the infection itself.
The drug is absorbed systemically and excreted in the urine where it produces a reddish-orange colour.
Onset of symptomatic relief is usually rapid, often within hours of the first dose.
Clinical Terms
- INN
- Phenazopyridine.
- ATC Code
- G04BX06 for other urologicals.
- Topical Urinary Analgesic
- Acts locally on urinary tract mucosa to reduce pain signalling.
- Methemoglobinaemia
- A rare condition where haemoglobin cannot carry oxygen effectively; treatable with methylene blue.
- Haemolytic Anaemia
- Red cell breakdown seen in G6PD deficiency when exposed to certain oxidising drugs.
[Diagram placeholder: Oral Dose → Systemic Absorption → Renal Excretion → Local Urinary Tract Analgesia]
- Onset: Often rapid symptomatic relief within hours.
- Limitation: No antimicrobial activity and not a substitute for antibiotics when infection is present.
Indications & Off-Label Uses
Approved Indications By TGA (Advice To Verify)
Internationally, phenazopyridine is indicated for short-term symptomatic relief of dysuria associated with urinary tract infection and for discomfort after urological procedures.
In Australia, verify approved indications and authorisations with the TGA ARTG before recommending use.
Off-Label Uses In Australian Clinical Practice
| Indication | Typical Dose | Evidence Strength |
|---|---|---|
| Acute Dysuria (symptomatic relief) | 100–200 mg TID, max 2 days with antibiotics | Moderate (clinical trials support symptomatic benefit) |
| Post-Urological Instrumentation | 200 mg TID as directed; short-term use | Low–Moderate (used peri-procedurally for comfort) |
- Off-label usage for chronic pelvic pain or interstitial cystitis is not routinely recommended due to limited evidence and increased risk with prolonged use.
- Red-flag uses: new haematuria, systemic symptoms, suspected complicated UTI — require specialist review.
- Do not use phenazopyridine for more than 48 hours without clinical reassessment.
Key Clinical Findings (Evidence Summary 2022–2026)
- Randomised trials and clinical reviews consistently show phenazopyridine reduces dysuria severity quickly but offers no antibacterial benefit — evidence grade: RCTs = moderate.
- There is no demonstrated advantage beyond 48 hours when used with appropriate antibiotics — evidence grade: moderate.
- Safety signals remain focused on rare but serious events including haemolytic anaemia and methemoglobinaemia, particularly in G6PD-deficient patients — evidence grade: observational = low–moderate.
- Renal and hepatic adverse events are rare but reported with prolonged or high-dose use; caution in patients with pre-existing disease — evidence grade: case reports/observational = low.
- Guidance emphasises pharmacist screening, limiting duration, and advising labs about urine colour changes to avoid misdiagnosis on dipstick tests — evidence grade: consensus/recommendation = low–moderate.
Always cross-check the latest TGA and therapeutic guidelines before prescribing or supplying phenazopyridine.
Alternatives Matrix
PBS-Listed Alternatives Comparison Table
| Agent | Mechanism | Symptom Relief | PBS Status (Verify) | Key Safety Notes |
|---|---|---|---|---|
| Phenazopyridine | Topical urinary analgesic | Rapid dysuria relief | Check PBS | Urine discolouration; contraindicated in G6PD and severe renal failure |
| Methenamine | Urinary antiseptic (prophylactic) | Not for acute symptomatic relief | Often PBS-listed for prophylaxis (verify) | Requires acidic urine; not suitable for acute relief |
| Flavoxate (Urispas) | Antispasmodic | Relieves bladder spasm-related symptoms | Check PBS | Anticholinergic side effects; dry mouth, constipation |
| Antibiotics | Systemic antibacterial | Treats infection, not immediate analgesia | PBS-listed depending on agent | Use guided by culture/susceptibility and clinical judgement |
Pros And Cons Checklist
- Phenazopyridine — Pro: rapid dysuria relief; Con: urine discolouration, contraindications, short duration only.
- Methenamine — Pro: useful for recurrent UTI prophylaxis; Con: not for acute symptomatic relief.
- Antispasmodics — Pro: help if bladder spasm is prominent; Con: systemic anticholinergic effects.
- Antibiotics — Pro: required to eradicate bacterial UTI when indicated; Con: not an immediate analgesic, requires correct selection.
Common Questions (Community Pharmacy FAQs)
- Will it stain clothing? Yes — urine may be red/orange; advise using dark or older bedding and prompt laundering.
- How long before I feel better? Many patients notice improvement within hours of the first dose.
- Can I take it with antibiotics? Yes for symptomatic relief, but limit to a maximum of 48 hours when used with antibiotics.
- Is it safe in pregnancy? Safety data are insufficient; avoid unless a prescriber advises it is necessary.
- When should I see a GP or ED? Fever, flank pain, blood in the urine, worsening symptoms, or any systemic signs require urgent review.
Pharmacist counselling checklist:
- Confirm allergies and hypersensitivity history.
- Ask about renal disease, liver disease and G6PD status.
- Check pregnancy and breastfeeding status.
- Review concurrent medications and recent antibiotic use.
- Confirm symptom duration and severity; advise follow-up within 48 hours.
Price & Access Comparison
Comparison Table — Pharmacy/Source, Typical Price Range, PBS Subsidy Status, Prescription Required
| Source | Typical Price Range | PBS Subsidy | Prescription Required |
|---|---|---|---|
| Chemist Warehouse | Estimate: verify live price | Verify | Likely |
| Priceline | Estimate: verify live price | Verify | Likely |
| TerryWhite Chemmart | Estimate: verify live price | Verify | Likely |
| Accredited Online Pharmacy | Estimate: verify live price | Verify | Likely |
| Import / Special Access | Estimate: verify live price | Not usually subsidised | Yes |
Access Checklist — Major Chains, Online Pharmacies, Rural Vs Urban Availability
- Check local stock before advising a specific brand.
- Ask a pharmacist about generic versus branded import options.
- Use telehealth for timely scripts if in need of urgent symptomatic relief.
- Plan supply for rural patients — allow extra delivery time or check nearest pharmacy with stock.
- Confirm PBS listing and subsidy before discussing patient out-of-pocket cost.
Registration & Regulation
TGA Approval
Phenazopyridine’s regulatory status varies internationally, and Australian clinicians must confirm TGA ARTG registration prior to recommending or supplying a product.
If a product is not registered in the ARTG, consider authorised import or special access schemes following TGA procedures.
PBS Subsidy Details And Import Rules
- ARTG
- Australian Register of Therapeutic Goods — check for product registration.
- PBS
- Pharmaceutical Benefits Scheme — verify subsidy listings before advising patients about cost.
- Special Access Scheme (SAS)
- Permits prescribing of unapproved medicines in certain circumstances under TGA oversight.
- Authorised Prescriber
- Health practitioners authorised to prescribe certain unapproved therapeutic goods under defined conditions.
Procedural checklist for clinicians and pharmacists:
- Search the TGA ARTG for phenazopyridine entries.
- Consult the PBS schedule for any subsidy or listing information.
- If not registered, consider authorised import or SAS, document clinical rationale and obtain informed consent.
- Record counselling and advise the patient about the non-registered status when applicable.
Storage & Handling
Household Storage In Australian Climate (Heat/Humidity)
Store phenazopyridine at 20–25°C and protect it from moisture and light.
Avoid leaving tablets in hot cars, direct sunlight or humid bathrooms common in some Australian climates.
Keep the medication in its original packaging and out of reach of children and pets.
Cold-Chain Handling For Pharmacies
- Maintain room temperature storage in the pharmacy and avoid exposure to high humidity.
- Monitor expiry dates on imported batches and label counselling points clearly.
- For compounded suspensions, follow local compounding and transport guidance; cold-chain is not routinely required unless specified.
Home storage checklist:
- Store in a cool, dry place away from sunlight.
- Discard if tablets appear discoloured or packaging is compromised.
- Do not use after the expiry date.
Guidelines For Proper Use (Pharmacist Counselling & Patient Advice)
Australian Pharmacist Counselling Style (Concise Script)
“Are you taking this for burning when passing urine?”
“Please confirm any kidney problems, G6PD deficiency, pregnancy or breastfeeding.”
“Recommended dosing is 100–200 mg three times a day for short-term relief, and not more than 48 hours when used with antibiotics.”
“Expect your urine to turn reddish-orange and it may stain fabrics; bring the packaging if you need tests.”
“Stop and seek urgent care if you get jaundice, breathlessness, severe fatigue, dark urine or a new rash.”
Patient Advice From PBS And National Health Authorities
- Confirm current medicines, allergies and relevant medical history before supply.
- Advise that phenazopyridine is symptomatic treatment only and not a substitute for antibiotics if a UTI is present.
- Provide a safety-net: see GP or ED if symptoms worsen or new systemic signs develop.
- Document counselling in the patient record and advise on PBS status if relevant.
Red-flag referral list:
- Fever or chills.
- Flank pain or severe loin tenderness.
- Persistent or worsening symptoms after 48 hours of treatment.
- Yellowing of the skin or eyes, breathlessness or signs of anaemia.
Delivery Across Australia
| City | Region | Delivery time |
|---|---|---|
| Sydney | New South Wales | 9-14 days |
| Melbourne | Victoria | 9-14 days |
| Brisbane | Queensland | 9-14 days |
| Perth | Western Australia | 9-14 days |
| Adelaide | South Australia | 9-14 days |
| Canberra | Australian Capital Territory | 9-14 days |
| Hobart | Tasmania | 9-14 days |
| Darwin | Northern Territory | 9-14 days |
| Gold Coast | Queensland | 9-14 days |
| Newcastle | New South Wales | 9-14 days |
| Wollongong | New South Wales | 14-21 days |
| Sunshine Coast | Queensland | 14-21 days |
| Geelong | Victoria | 14-21 days |
| Townsville | Queensland | 14-21 days |